Immunoregulatory Mechanisms of Treg Cells Induced by Tocilizumab
Status:
Completed
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
We can speculate that the best responders to tocilizumab should have multiple related
elements (Treg CD39, adenosine, IL-35) successfully induced and expressed in order to play
its beneficial role. The study of these elements and its pathways could help identify the
best responders to tocilizumab treatment.
Details
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau